Advertisement
Canada markets closed
  • S&P/TSX

    21,708.44
    +52.39 (+0.24%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • CAD/USD

    0.7262
    -0.0001 (-0.02%)
     
  • CRUDE OIL

    82.58
    -0.15 (-0.18%)
     
  • Bitcoin CAD

    87,438.59
    +3,052.22 (+3.62%)
     
  • CMC Crypto 200

    1,314.40
    +428.86 (+48.42%)
     
  • GOLD FUTURES

    2,395.30
    -2.70 (-0.11%)
     
  • RUSSELL 2000

    1,942.96
    -4.99 (-0.26%)
     
  • 10-Yr Bond

    4.6470
    +0.0620 (+1.35%)
     
  • NASDAQ futures

    17,512.75
    -34.50 (-0.20%)
     
  • VOLATILITY

    18.00
    -0.21 (-1.15%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     
  • CAD/EUR

    0.6820
    -0.0001 (-0.01%)
     

Veeva Launches Vault SiteDocs for Regulatory Documentation

Veeva's (VEEV) Vault SiteDocs Platform conducts high-quality, compliant clinical trials with greater visibility to researchers.

In a bid to reduce the administrative burden of managing regulatory documentation and trial information, Veeva Systems VEEV recently introduced a new application for clinical research centers — Veeva Vault SiteDocs.

The solution will effectively manage regulatory documentation and trial information to enhance clinical research.

Veeva partnered with IACT Health and Penn Medicine to launch Vault SiteDocs.

More About Veeva Vault SiteDocs

Veeva Vault SiteDocs conducts high-quality, compliant clinical trials with greater visibility to researchers. The platform examines document quality, completeness and accuracy.

ADVERTISEMENT

Strength in Product Portfolio

The company’s unique solutions include Veeva Vault, Veeva CRM, Veeva Network and VeevaOpenData. Veeva Vault is the first cloud-based content management system built specifically for the life sciences.

Veeva CRM is a customer relationship management platform that offers cloud-based solutions to reach customers on any channel. Notably, the company announced mobile innovations in the Veeva CRM platform, which provides information to field teams from any device. Furthermore, New Jersey-based Merck is increasing its use of multichannel Veeva CRM to additional markets, which includes Latin America and Asia Pacific.

Another cloud application of the company is Veeva Vault Training, which is designed to simplify role-based training across life sciences organizations as well as help quality teams remain audit-ready and compliant.

Veeva Network is a master data management platform that provides global, single-instance customer and product master solution.

Lastly, VeevaOpenData is a reference data platform.

Management has announced plans to develop an AI engine specific to commercial life sciences that will use Veeva Nitro as its data source. Management believes that AI is an important technology through which the companycan generate profits.

Earlier this year, Veeva also added customers for Vault QualityOne, which continues to make excellent progress.

The latest development is likely to enhance product portfolio in cloud-based healthcare services market.

Some of the healthcare giants that are raking billions through cloud-based services are Cerner Corporation CERN, athenahealth ATHN and Allscripts Healthcare MDRX.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Veeva Systems Inc. (VEEV) : Free Stock Analysis Report
 
athenahealth, Inc. (ATHN) : Free Stock Analysis Report
 
Allscripts Healthcare Solutions, Inc. (MDRX) : Free Stock Analysis Report
 
Cerner Corporation (CERN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research